{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T12:42:31Z","timestamp":1774701751665,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.carrev.2025.05.003","type":"journal-article","created":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T02:34:57Z","timestamp":1746239697000},"page":"102-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Hemocompatibility related complications in Impella 5+ patients treated with Bivalirudin and dual antiplatelet therapy: a SHEAR score evaluation"],"prefix":"10.1016","volume":"82","author":[{"given":"Marta","family":"Bandini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Querio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Utzeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Cardinale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Maj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Audo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Pappalardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2025.05.003_bb0005","doi-asserted-by":"crossref","unstructured":"M\u00f8ller J.E, Engstr\u00f8m T, Jensen L.O, Eiskj\u00e6r H, Mangner N, Polzin A et al. For the DanGer shock Investigators. Microaxial flow pump or standard Care in Infarct-Related Cardiogenic Shock. N Engl J Med, 2024 Apr 18;390(15):1382\u20131393. doi: https:\/\/doi.org\/10.1056\/NEJMoa2312572.","DOI":"10.1056\/NEJMoa2312572"},{"issue":"1","key":"10.1016\/j.carrev.2025.05.003_bb0010","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1053\/j.jvca.2012.07.019","article-title":"Bivalirudin versus heparin as an anticoagulant during extracorporeal membrane oxygenation: a case-control study","volume":"27","author":"Pieri","year":"2013","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.carrev.2025.05.003_bb0015","doi-asserted-by":"crossref","unstructured":"Bashline M, Di Bridge J, Klass W.J, Morelli B, Kaczorowski D, Schmidhofer M et al. Outcomes of systemic bivalirudin and sodium bicarbonate purge solution for Impella 5.5. Artif Organs 2023 Feb;47(2):361\u2013369. doi: https:\/\/doi.org\/10.1111\/aor.14428.","DOI":"10.1111\/aor.14428"},{"issue":"6","key":"10.1016\/j.carrev.2025.05.003_bb0020","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jtcvs.2006.01.048","article-title":"Heparin-induced thrombocytopenia in patients receiving mechanical circulatory support","volume":"131","author":"Schenk","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.carrev.2025.05.003_bb0025","doi-asserted-by":"crossref","unstructured":"Kaseer Pharm H, Soto-Arenall Pharm M, Sanghavi D, Moss J, Ratzlaff R, Pham Si et al. Heparin vs bivalirudin anticoagulation for extracorporeal membrane oxygenation. J Card Surg. 2020 Apr;35(4):779\u2013786. doi: https:\/\/doi.org\/10.1111\/jocs.14458","DOI":"10.1111\/jocs.14458"},{"issue":"3","key":"10.1016\/j.carrev.2025.05.003_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102375","article-title":"Ticagrelor vs clopidogrel when coadministered with bivalirudin in patients with acute coronary syndrome undergoing percutaneous coronary intervention","volume":"8","author":"Li","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"issue":"10366","key":"10.1016\/j.carrev.2025.05.003_bb0035","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(22)01999-7","article-title":"Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomized trial","volume":"400","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2025.05.003_bb0040","doi-asserted-by":"crossref","unstructured":"Pappalardo F, Delmas C, Bertoldi C, Montisci A, Nap A, Ott S et al. Haemocompatibility related adverse events in patients with temporary mechanical circulatory support: the SHEAR (scoring Haemostasis events and assessment for risk) score. J Cardiothorac Vasc Anesth 2024 Dec;38(12):3234\u20133251. doi: https:\/\/doi.org\/10.1053\/j.jvca.2024.08.010.","DOI":"10.1053\/j.jvca.2024.08.010"},{"key":"10.1016\/j.carrev.2025.05.003_bb0045","doi-asserted-by":"crossref","unstructured":"Dhruva S.S, Ross J.S, Mortazavi B.J, Hurley N.C, Krumholz H.M, Curtis J.P et al. Association of use of an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump with in-hospital mortality and major bleeding among patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 2020 Feb 25;323(8):734\u2013745. doi: https:\/\/doi.org\/10.1001\/jama.2020.0254.","DOI":"10.1001\/jama.2020.0254"},{"key":"10.1016\/j.carrev.2025.05.003_bb0050","doi-asserted-by":"crossref","unstructured":"Miller P.E, Bromfield S.G, Ma Q, Crawford G, Whitney J, DeVriesA et al. Clinical outcomes and cost associated with an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump in patients presenting with acute myocardial infarction complicated by cardiogenic shock. JAMA Intern Med 2022;182(9): 926\u2013933.","DOI":"10.1001\/jamainternmed.2022.2735"},{"key":"10.1016\/j.carrev.2025.05.003_bb0055","doi-asserted-by":"crossref","unstructured":"Van Edom C.J, Gramegna M, Baldetti L, Beneduce A, Castelein T, Dauwe D et al.. Management of Bleeding and Hemolysis during Percutaneous Microaxial Flow Pump Support: a practical approach. JACC Cardiovasc Interv 2023 Jul 24;16(14):1707\u20131720. doi: https:\/\/doi.org\/10.1016\/j.jcin.2023.05.043.","DOI":"10.1016\/j.jcin.2023.05.043"},{"key":"10.1016\/j.carrev.2025.05.003_bb0060","doi-asserted-by":"crossref","unstructured":"Van Edom C.J, Swol J, Castelein T, Gramegna M, Huber K, Leonardi S et al. European practices on antithrombotic management during percutaneous mechanical circulatory support in adults: a survey of the Association for Acute CardioVascular care of the ESC and the European branch of the extracorporeal life support organization. Eur Heart J Acute Cardiovasc Care (2024) 13, 458\u2013469. https:\/\/doi.org\/10.1093\/ehjacc\/zuae040.","DOI":"10.1093\/ehjacc\/zuae040"},{"key":"10.1016\/j.carrev.2025.05.003_bb0065","unstructured":"Berlioz B.E, Patel P, Sanghavi D.K. Bivalirudin. StatPearls Publishing; 2024 Jan. PMID: 32491755."},{"key":"10.1016\/j.carrev.2025.05.003_bb0070","doi-asserted-by":"crossref","unstructured":"Galli M, Gargiulo G, Benenati S, Mehran R, Angiolillo D.J et al. Bivalirudin plus a high-dose infusion versus heparin in patients with acute coronary syndrome. Eur Heart J Cardiovasc Pharmacother 2023. doi: https:\/\/doi.org\/10.1093\/ehjcvp\/pvad029.","DOI":"10.1093\/eurheartj\/ehad655.2834"},{"issue":"10366","key":"10.1016\/j.carrev.2025.05.003_bb0075","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(22)01999-7","article-title":"Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomized trial","volume":"400","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2025.05.003_bb0080","doi-asserted-by":"crossref","unstructured":"Bikdeli B, Erlinge D, Valgimigli M, Kastrati A, Han Y, Steg P.G et al. Bivalirudin versus heparin during PCI in NSTEMI: individual patient data Meta-analysis of large randomized trials. Circulation 2023 Oct 17;148(16):1207\u20131219.","DOI":"10.1161\/CIRCULATIONAHA.123.063946"},{"key":"10.1016\/j.carrev.2025.05.003_bb0085","article-title":"Bivalirudin in acute coronary syndromes","volume":"21(12):901-911","author":"Galli","year":"2023","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"2","key":"10.1016\/j.carrev.2025.05.003_bb0090","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1055\/s-0039-1700872","article-title":"Individual patient data pooled analysis of randomized trials of Bivalirudin versus heparin in acute myocardial infarction: rationale and methodology","volume":"120","author":"Bikdeli","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.carrev.2025.05.003_bb0095","doi-asserted-by":"crossref","unstructured":"A Byrne R, Rossello X, Coughlan J, Barbato E, Berry C, Chieffo A et al. 2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC). European Heart Journal, Vol. 44, Issue 38, 7 October 2023, 3720\u20133826, https:\/\/doi.org\/10.1093\/eurheartj\/ehad191","DOI":"10.1093\/eurheartj\/ehad191"},{"key":"10.1016\/j.carrev.2025.05.003_bb0100","doi-asserted-by":"crossref","unstructured":"Stone G.W, Akinmolayemi O, Stables R.H. Is bivalirudin ready for a comeback? Pros and cons EuroIntervention 2024 Aug 5;20(15):e912-e914. doi: https:\/\/doi.org\/10.4244\/EIJ-E-24-00013.","DOI":"10.4244\/EIJ-E-24-00013"},{"key":"10.1016\/j.carrev.2025.05.003_bb0105","doi-asserted-by":"crossref","unstructured":"Carly F, Levito M.N, Rivosecchi R, Bashline M, Slocum B, Kilicet A et al. Outcomes of systemic anticoagulation with bivalirudin for Impella 5.0. Int J Artif Organs 2021 Oct;44(10):681\u2013686. doi: https:\/\/doi.org\/10.1177\/03913988211032238.","DOI":"10.1177\/03913988211032238"},{"issue":"6","key":"10.1016\/j.carrev.2025.05.003_bb0110","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jtcvs.2006.01.048","article-title":"Heparin induced thrombocytopenia in patients receiving mechanical circulatory support","volume":"131","author":"Schenk","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.carrev.2025.05.003_bb0115","doi-asserted-by":"crossref","unstructured":"Hohlfelder B, Militello M.A, Tong M.Z, Soltesz E.G, Wanek M.R et al. Anticoagulation with temporary Impella device in patients with heparin induced thrombocytopenia: a case series. Int J Artif Organs 2021; 44: 367\u2013370.","DOI":"10.1177\/0391398820964810"},{"key":"10.1016\/j.carrev.2025.05.003_bb0120","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction","volume":"329","author":"Investigators","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2025.05.003_bb0125","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/eurheartj\/ehx036","article-title":"The burden of haemocompatibility with left ventricular assist systems: a complex weave","volume":"40","author":"Mehra","year":"2019","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.carrev.2025.05.003_bb0130","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1177\/10600280231206130","article-title":"Evaluation of newly integrated Bivalirudin titration protocol in patients with mechanical circulatory support","volume":"58","author":"Mitchell","year":"2024","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.carrev.2025.05.003_bb0135","doi-asserted-by":"crossref","unstructured":"Naidu S.S, Baran D.A, Jentzer J.C, Hollenberg S.M, Van Diepen S, Basiret M.B et al. SCAI SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incorporation of Validation Studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), European Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International Society for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Society of Thoracic Surgeons (STS) in December 2021. J Am Coll Cardiol. 2022 Mar 8;79(9):933\u2013946. doi: https:\/\/doi.org\/10.1016\/j.jacc.2022.01.018.","DOI":"10.1016\/j.jacc.2022.01.018"},{"key":"10.1016\/j.carrev.2025.05.003_bb0140","article-title":"Switch to a bicarbonate-based Impella CP\u2122 purge solution in a patient with haemothorax: a case report","volume":"7(1):ytad022","author":"Van Edom","year":"2023","journal-title":"Eur Heart J Case Rep"},{"key":"10.1016\/j.carrev.2025.05.003_bb0145","doi-asserted-by":"crossref","unstructured":"Fabrizio C, Levito MN, Rivosecchi R, Bashline M, Slocum B et al. Outcomes of systemic anticoagulation with bivalirudin for Impella 5.0. Int J Artif Organs 2021 Oct;44(10):681\u2013686. doi: https:\/\/doi.org\/10.1177\/03913988211032238.","DOI":"10.1177\/03913988211032238"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838925002258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838925002258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:24:29Z","timestamp":1770855869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838925002258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":29,"alternative-id":["S1553838925002258"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2025.05.003","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemocompatibility related complications in Impella 5+ patients treated with Bivalirudin and dual antiplatelet therapy: a SHEAR score evaluation","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2025.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}